• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $MCTA

    Charming Medical Limited

    Subscribe to $MCTA
    $MCTA
    Misc Health and Biotechnology Services
    Health Care

    IPO Year: 2025

    Exchange: NASDAQ

    Recent Analyst Ratings for Charming Medical Limited

    DatePrice TargetRatingAnalyst
    See more ratings

    Charming Medical Limited SEC Filings

    View All

    SEC Form 6-K filed by Charming Medical Limited

    6-K - Charming Medical Ltd (0002035992) (Filer)

    11/13/25 6:01:23 AM ET
    $MCTA
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 6-K filed by Charming Medical Limited

    6-K - Charming Medical Ltd (0002035992) (Filer)

    10/28/25 5:20:01 PM ET
    $MCTA
    Misc Health and Biotechnology Services
    Health Care

    Charming Medical Limited Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nasdaq Halts Charming Medical Limited

    NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) --  The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading is halted in Charming Medical Limited (NASDAQ:MCTA) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading suspension in MCTA from 04:00:00 on November 12, 2025 to 23:59:00 on November 25, 2025. The last sale price of the company's ordinary shares was $29.355.  More information about the SEC's order can be found at https://www.sec.gov/files/litigation/suspensions/2025/34-104176.pdf. Trading will remain halted until Charming Medical Limited has fully satisfied Nasdaq's request for additional information. For news

    11/26/25 7:00:00 AM ET
    $MCTA
    $NDAQ
    Misc Health and Biotechnology Services
    Health Care
    Investment Bankers/Brokers/Service
    Finance

    Charming Medical Limited Announces Full Exercise of Representative's Over-allotment Option

    HONG KONG, Oct. 28, 2025 /PRNewswire/ -- Charming Medical Limited (NASDAQ:MCTA) (the "Company"), a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products, today announced, in connection with its previously announced initial public offering (the "Offering") of 1,600,000 Class A ordinary shares, par value $0.0001 per share (the "Class A Ordinary Shares") at a price of $4.00 per share (the "Public Offering Price"), Cathay Securities, Inc., the representative of the underwriters (the "Representative") of the Offering, has exercised its over-allotment option (the "Over-allotment") in full to purchase an additional 240,000 Class A Ordinary Shares at the Publ

    10/28/25 4:15:00 PM ET
    $MCTA
    Misc Health and Biotechnology Services
    Health Care